Back
Sarepta Therapeutics Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
31
SRPT
Sarepta Therapeutics
Last Price:
124.92
Seasonality Move:
11.13%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Sarepta Therapeutics Price Quote
$124.92
-0.09 (1.5%)
(Updated: November 6, 2024 at 5:27 AM ET)
Sarepta Therapeutics Key Stats
Sell
31
Sarepta Therapeutics (SRPT)
is a Sell
Day range:
$121.18 - $125.25
52-week range:
$75.85 - $173.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.12
P/B ratio:
11.07%
Volume:
825.6K
Avg. volume:
793.8K
1-year change:
60.25%
Market cap:
$11.9B
Revenue:
$1.2B
EPS:
$0.74
How Much Does Sarepta Therapeutics Make?
-
How Much Are Sarepta Therapeutics's Sales Annually?
SRPT Revenues are $1.2B -
How Much Profit Does Sarepta Therapeutics's Make A Year?
SRPT net income is -$536M
Is Sarepta Therapeutics Growing As A Company?
-
What Is Sarepta Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.39% -
What Is Sarepta Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Sarepta Therapeutics Stock Price Performance
-
Did Sarepta Therapeutics Stock Go Up Last Month?
Sarepta Therapeutics share price went up by 3.83% last month -
Did SRPT's Share Price Rise Over The Last Year?
SRPT share price rose by 60.25% over the past 1 year
What Is Sarepta Therapeutics 52-Week High & Low?
-
What Is Sarepta Therapeutics’s 52-Week High Share Price?
Sarepta Therapeutics has traded as high as $173.25 over the past 52 weeks -
What Is Sarepta Therapeutics’s 52-Week Low Share Price?
Sarepta Therapeutics has traded as low as $75.85 over the past 52 weeks
Sarepta Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sarepta Therapeutics?
-
How Much Debt Does Sarepta Therapeutics Have?
Total long term debt quarterly is $1.2B -
How Much Cash Does Sarepta Therapeutics Have?
Cash and short term investments quarterly total is $1.5B -
What Is Sarepta Therapeutics’s Book Value Per Share?
Book value per share is 11.30
Is Sarepta Therapeutics Cash Flow Positive?
-
What Is SRPT Cash Flow From Operations?
Cash flow from operations (TTM) is -$396.5M -
What Is Sarepta Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $79.4M -
What Is Sarepta Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$154.7M
Sarepta Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
SRPT return on invested capital is 2.24% -
What Is Sarepta Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 1.46% -
What Is SRPT Return On Equity?
ROE is a measure of profitability and is 5.37%
Sarepta Therapeutics Earnings Date & Stock Price
-
What Is Sarepta Therapeutics's Stock Price Today?
A single share of SRPT can be purchased today for 125.01 -
What Is Sarepta Therapeutics’s Stock Symbol?
Sarepta Therapeutics trades on the nasdaq under the ticker symbol: SRPT -
When Is Sarepta Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Sarepta Therapeutics is scheduled on November 6, 2024 -
When Is SRPT's next ex-dividend date?
Sarepta Therapeutics's next ex-dividend date is November 6, 2024 -
How To Buy Sarepta Therapeutics Stock?
You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sarepta Therapeutics Competitors
-
Who Are Sarepta Therapeutics's Competitors?
Below is a list of companies who compete with Sarepta Therapeutics or are related in some way:
Sarepta Therapeutics Dividend Yield
-
What Is SRPT Dividend Yield?
Sarepta Therapeutics’s dividend yield currently is 0% -
What Is Sarepta Therapeutics’s Payout Ratio?
Sarepta Therapeutics’s payout ratio is 0% -
When Did Sarepta Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Sarepta Therapeutics’s Dividend Per Share?
Sarepta Therapeutics pays a dividend of $0.00 per share
Sarepta Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -5.47% |
| Revenue: | 38.93% | -6.3% |
Analyst Recommendations
| Buy Recommendations: | 12 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 189.91 |
| Upside from Last Price: | 51.92% |